Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation.

Chan AS, Jonas AB, Qiu X, Ottoson NR, Walsh RM, Gorden KB, Harrison B, Maimonis PJ, Leonardo SM, Ertelt KE, Danielson ME, Michel KS, Nelson M, Graff JR, Patchen ML, Bose N.

PLoS One. 2016 Nov 3;11(11):e0165909. doi: 10.1371/journal.pone.0165909. eCollection 2016.

2.

Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer.

Fields JZ, Gao Z, Gao Z, Lewis M, Maimonis P, Harvey J, Lynch HT, Boman BM.

J Lab Clin Med. 2004 Jan;143(1):59-66.

PMID:
14749686
3.

Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy.

Harris LN, Liotcheva V, Broadwater G, Ramirez MJ, Maimonis P, Anderson S, Everett T, Harpole D, Moore MB, Berry DA, Rizzeri D, Vredenburgh JJ, Bentley RC.

J Clin Oncol. 2001 Mar 15;19(6):1698-706.

PMID:
11250999
4.

Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma.

Treon SP, Maimonis P, Bua D, Young G, Raje N, Mollick J, Chauhan D, Tai YT, Hideshima T, Shima Y, Hilgers J, von Mensdorff-Pouilly S, Belch AR, Pilarski LM, Anderson KC.

Blood. 2000 Nov 1;96(9):3147-53.

5.

Clinical use of serum c-erbB-2 in patients with ovarian masses.

Cheung TH, Wong YF, Chung TK, Maimonis P, Chang AM.

Gynecol Obstet Invest. 1999;48(2):133-7.

PMID:
10461006
6.

The prognostic significance of c-erbB-2 serum protein in metastatic breast cancer.

Fehm T, Maimonis P, Katalinic A, Jäger WH.

Oncology. 1998 Jan-Feb;55(1):33-8.

PMID:
9428373
7.

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients.

Fehm T, Maimonis P, Weitz S, Teramoto Y, Katalinic A, Jäger W.

Breast Cancer Res Treat. 1997 Mar;43(1):87-95.

PMID:
9065602
8.
9.
10.

A new radioimmunoassay detecting early stages of colon cancer: a comparison with CEA, AFP, and Ca 19-9.

Chester SJ, Maimonis P, Vanzuiden P, Finklestein M, Bookout J, Vezeridis MP.

Dis Markers. 1991 Sep-Oct;9(5):265-71.

PMID:
1724634
11.
12.

Detection and characterization of a high molecular weight human lung carcinoma-associated glycoprotein.

Maimonis P, Hayes DF, O'Hara C, Kufe D.

Cancer Res. 1990 Oct 15;50(20):6738-43.

13.

An analysis of immunocomplexes for the detection of the early stages of colon cancer.

Chester SJ, Maimonis P, Meitner PA, Vezeridis MP.

Cancer. 1990 Mar 15;65(6):1338-44.

PMID:
2306682
14.

Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.

Suit HD, Maimonis P, Michaels HB, Sedlacek R.

Radiat Res. 1981 Aug;87(2):360-7. No abstract available.

PMID:
7268001
15.

Anaesthesia and efficacy of hyperbaric oxygen in radiation therapy.

Suit HD, Maimonis P, Rich TA, Sedlacek RS.

Br J Radiol. 1979 Mar;52(615):244. No abstract available.

PMID:
435703

Supplemental Content

Loading ...
Support Center